Unknown PHASE4 INTERVENTIONAL 2-arm NCT04709770

Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis (PrepDial)

Comparison of Low-volume Versus High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis: a Randomized Non-inferiority Trial

Sponsor: Alfasigma S.p.A.

Conditions Chronic Kidney Diseases Colon Cancer Colon Polyp Dialysis; Complications

Interventions 2-liters polyethylene glycol with citrate and simethicone 4-liters polyethylene glycol with simethicone Low-residue diet

Updated 4 times since 2021 Last updated: Jan 13, 2021 Started: Feb 1, 2021 Primary completion: Mar 1, 2022 Completion: Mar 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chronic Kidney Diseases and Colon Cancer, this trial is ongoing. The trial is conducted by Alfasigma S.p.A. and has accumulated 4 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Feb 2021 — Feb 2023 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alfasigma S.p.A.
Alfredo Di Leo

Data source: University of Bari

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.